Portfolio Company Headlines

October 13, 2015

St. Louis, MO
EndoStim’s neurostimulation therapy for GERD receives permanent reimbursement coverage in Germany

October 6, 2015

Austin, TX
Baxter, Boston back TVA in $15M Round to Ease Hemodialysis Vascular Access

April 30, 2015

Austin, TX
Mirna Therapeutics Secures $41.8 Million Series D Financing to Advance Oncology microRNA Pipeline

April 14, 2015

Cleveland, OH
IBM Acquires Explorys to Accelerate Cognitive Insights for Health and Wellness

February 26, 2015

San Francisco, CA
Lyric Pharmaceuticals Announces $20.4M Series A Funding Round

February 18, 2015

La Jolla, CA
Laguna Pharmaceuticals Completes $30 Million Series B Financing, Appoints Industry Veteran Bob Baltera as CEO

January 30, 2015

North Hollywood, CA
IPC Healthcare Acquires Selected Assets of Hospitalists Now, Inc., Expanding IPC’s Presence in Florida

December 15, 2014

Boston, MA
Best Doctors, Inc. Acquires Rise Health to Accelerate Expansion of its Digital Health Solutions Focused on Helping People Get the Right Diagnosis and Treatment

November 4, 2014

Boston, MA
AbVitro Inc. Appoints Samuel Broder, M.D. to its Board of Directors and Scientific Advisory Board

September 15, 2014

Georgetown, TX
Molecular Templates Announces Completion of $12M Series C Financing

September 13, 2014

Washington, DC
Clean-Tavi trial shows Claret Medical cerebral protection system dramatically reduces brain lesions and neurological events following transcatheter aortic valve replacement (TAVR)

September 8, 2014

St. Louis, MO
EndoStim Files Registration Statement for Proposed Initial Public Offering of Common Stock

September 8, 2014

Georgetown, TX
Molecular Templates announces FDA approval of investigational new drug application for CD20 internalizing immunotoxin MT-3724

September 6, 2014

Santa Rosa, CA
Claret Medical® Raises up to $18 Million in Series B Financing to Advance the Field of Cerebral Protection

February 4, 2014

Austin, TX
Lumos Pharma Announces Series A Financing